Gastric bypass improves long-term T2DM remission even after weight recurrence
Adults who have obesity and type 2 diabetes are much more likely to see their diabetes stay in remission if they undergo gastric bypass...
top of page
Browse by category
Search
Intragastric expandable capsule results in clinically meaningful reduction in body weight
In a 24-week trial with participants living with overweight or obesity, a 2.24g intragastric expandable capsules twice daily led to a...
BARICO: Bariatric surgery leads to cognitive improvement in approximately 40% of participants
In a study including 133 adults with severe obesity who underwent bariatric surgery, cognitive function, inflammatory biomarkers,...
Patients’ perceptions of living with obesity and the prospect of having bariatric surgery
Integrating mindfulness, mindful eating and self-compassion before and after bariatric surgery could be beneficial for patients to...
The impact of bariatric surgery on the bone health of paediatric and adolescents
Bariatric surgery is highly effective at achieving weight loss in paediatric patients however sleeve gastrectomy (SG) and...
Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression
Tetra Pharm Technologies has reached a significant in developing its compound for appetite suppression, TPT0701, following the successful...
PROSS outcomes: Re-redo bariatric surgery is effective but carries significant risk of complications
Although Re-redo bariatric surgery is an effective treatment for obesity it carries a significant risk of complications, according to the...
Journal Watch 7/02/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Innovent's mazdutide accepted by China’s NMPA for chronic weight management
Innovent Biologics’ New Drug Application (NDA) for mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1 receptor (GLP-1R) and...
FDA approves Veru’s trial with Enobosarm to treat muscle loss associated with weight loss drugs
The FDA has cleared Veru’s Investigational New Drug (IND) application for its Phase 2b clinical study to evaluate enobosarm, an oral...
Browse by tag
bottom of page